Molecular cross talk between misfolded proteins in animal models of alzheimer's and prion diseases

Journal of Neuroscience

Volumn 30, Issue 13, 2010, Pages 4528-4535

  Morales, Rodrigo ^a,b,c   Estrada, Lisbell D ^b,c   Diaz Espinoza, Rodrigo ^a,b   Morales Scheihing, Diego ^a   Jara, Maria C ^a   Castilla, Joaquin ^b,d,e   Soto, Claudio ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF CHILE   (Chile)

^d NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

^e BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; HISTOPATHOLOGY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRION DISEASES; PRIONS; PROTEIN FOLDING; PRPSC PROTEINS;

EID: 77950633906     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5924-09.2010     Document Type: Article

References (51)

1. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61: 661-666. (Pubitemid 38637681)
2. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA, Caughey B (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5: 211-212. (Pubitemid 351325633)
3. Bradley R, Liberski PP (2004) Bovine spongiform encephalopathy (BSE): the end of the beginning or the beginning of the end? Folia Neuropathol 42 [Suppl A]: 55-68.
4. Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL 3rd (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57: 39-46.
5. Brown P, Jannotta F, Gibbs CJ Jr, Baron H, Guiroy DC, Gajdusek DC (1990) Coexistence of Creutzfeldt-Jakob disease and Alzheimer's disease in the same patient. Neurology 40: 226-228. (Pubitemid 20099428)
6. Bugiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR, Tagliavini F, Ghetti B (1993) Beta PP participates in PrP-amyloid plaques of Gerstmann-Straussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52: 64-70. (Pubitemid 23016640)
7. Castilla J, Saá P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121: 195-206.
8. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366. (Pubitemid 44118036)
9. Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, Alpers MP (2006) Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 367: 2068-2074. (Pubitemid 43949290)
10. Cummings JL (2004) Alzheimer's disease. N Engl J Med 351: 56-67.
11. Dickson DW (2001) Neuropathology of Alzheimer's disease and other dementias. Clin Geriatr Med 17: 209-228. (Pubitemid 32429328)
12. Diedrich J, Wietgrefe S, Zupancic M, Staskus K, Retzel E, Haase AT, Race R (1987) The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease. Microb Pathog 2: 435-442. (Pubitemid 17109085)
13. Fernandez-Alonso J, Rios-Camacho C, Valenzuela-Castaño A, Hernanz-Mediano W (1994) Mixed systemic amyloidosis in a patient receiving long term haemodialysis. J Clin Pathol 47: 560-561. (Pubitemid 24294025)
14. Giasson BI, Lee VM, Trojanowski JQ (2003) Interactions of amyloidogenic proteins. Neuromolecular Med 4: 49-58.
15. Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27: 570-575.
16. Goldsbury CS, Wirtz S,Mualler SA, Sunderji S, Wicki P, Aebi U, Frey P (2000) Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors. J Struct Biol 130: 217-231.
17. Guo JP, Arai T, Miklossy J, McGeer PL (2006) Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc Natl Acad Sci U S A 103: 1953-1958. (Pubitemid 43228799)
18. Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 96: 116-122. (Pubitemid 28356523)
19. Haraguchi T, Terada S, Ishizu H, Sakai K, Tanabe Y, Nagai T, Takata H, Nobukuni K, Ihara Y, Kitamoto T, Kuroda S (2009) Coexistence of Creutzfeldt-Jakob disease, Lewy body disease, and Alzheimer's disease pathology: an autopsy case showing typical clinical features of Creutzfeldt-Jakob disease. Neuropathology 29: 454-459.
20. Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385-407.
21. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C (2003) Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 22: 5435-5445. (Pubitemid 37279953)
22. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
23. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53: 474-481. (Pubitemid 38174565)
24. Jarrett JT, Lansbury PT Jr (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058.
25. Johan K, Westermark G, EngströmU, Gustavsson A, Hultman P, Westermark P (1998) Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A 95: 2558-2563. (Pubitemid 28145981)
26. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10: 524-530.
27. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457: 1128-1132.
28. Leuba G, Saini K, Savioz A, Charnay Y (2000) Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology. JAMA 283: 1689-1691. (Pubitemid 30196207)
29. Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain 104: 535-558.
30. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, JuckerM (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313: 1781-1784. (Pubitemid 44454153)
31. Morales R, Abid K, Soto C (2007) The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 1772: 681-691. (Pubitemid 46887653)
32. Morimoto RI (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22: 1427-1438.
33. Moss RJ, Mastri AR, Schut LJ (1988) The coexistence and differentiation of late onset Huntington's disease and Alzheimer's disease.Acase report and review of the literature. J Am Geriatr Soc 36: 237-241.
34. Muramoto T, Kitamoto T, Koga H, Tateishi J (1992) The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration. Acta Neuropathol 84: 686-689.
35. Nelson R, EisenbergD (2006) Structural models of amyloid-like fibrils. Adv Protein Chem 73: 235-282.
36. O'Nuallain B, Williams AD, Westermark P, Wetzel R (2004) Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279: 17490-17499. (Pubitemid 38560512)
37. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, HooperNM (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A 104: 11062-11067. (Pubitemid 47175226)
38. Permanne B, Adessi C, Saborio GP, Fraga S, Frossard MJ, Van Dorpe J, Dewachter I, Banks WA, Van Leuven F, Soto C (2002) Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J 16: 860-862.
39. Popescu A, Lippa CF, Lee VM, Trojanowski JQ (2004) Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 61: 1915-1919. (Pubitemid 39612952)
40. Prusiner SB (2004) Early evidence that a protease-resistant protein is an active component of the infectious prion. Cell 116 [2 Suppl]: S109.
41. Rajput AH, Rozdilsky B, RajputA (1993) Alzheimer's disease and idiopathic Parkinson's disease coexistence. J Geriatr Psychiatry Neurol 6: 170-176.
42. Rutkowski DT, Kaufman RJ (2004) A trip to the ER: coping with stress. Trends Cell Biol 14: 20-28.
43. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924: 17-25.
44. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B (2005) The most infectious prion protein particles. Nature 437: 257-261.
45. Soto C (2001) Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498: 204-207. (Pubitemid 32539204)
46. Soto C, Castaño EM, Prelli F, Kumar RA, Baumann M (1995) Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett 371: 110-114.
47. Soto C, Estrada L, Castilla J (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 31: 150-155. (Pubitemid 43357995)
48. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273: 729-739. (Pubitemid 27488813)
49. Tagliavini F, Giaccone G, Frangione B, BugianiO (1988) Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett 93: 191-196.
50. Tsuchiya K, Yagishita S, Ikeda K, Sano M, Taki K, Hashimoto K, Watabiki S, MizusawaH (2004) Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD. Neuropathology 24: 46-55. (Pubitemid 38391494)
51. Yoshida H, Terada S, Ishizu H, Ikeda K, Hayabara T, Ikeda K, Deguchi K, Touge T, Kitamoto T, Kuroda S (2009) An autopsy case of Creutzfeldt-Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology. Neuropathology. Advance online publication. Retrieved February 21, 2010. doi: 10.1111/j.1440-1789.2009.01048.x.